PSIX trades 208.1% below Wall Street's consensus target of $107.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PSIX achieves its forward estimates and maintains a stable P/E multiple of 14.6x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Power Solutions International, Inc. (PSIX) has a Wall Street consensus price target of $107.00, based on estimates from 6 covering analysts. With the stock currently trading at $34.73, this represents a potential upside of +208.1%. The company has a market capitalization of $801M.
Analyst price targets range from a low of $107.00 to a high of $107.00, representing a 0% spread in expectations. The median target of $107.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, PSIX trades at a trailing P/E of 7.0x and forward P/E of 14.6x. Analysts expect EPS to grow -46.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $26.79, with bear and bull scenarios of $16.88 and $35.30 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
GNRCGenerac Holdings Inc. | $13.8B | $235.80 | $297.20 | +26.0% | Buy | 26.4x | 39 |
HLIOHelios Technologies, Inc. | $2.6B | $80.01 | $82.67 | +3.3% | Buy | 31.7x | 13 |
DCGODocGo Inc. | $59M | $0.60 | — | — | — | — | — |
PESIPerma-Fix Environmental Services, Inc. | $266M | $14.34 | $18.00 | +25.5% | Hold | — | 1 |
TWINTwin Disc, Incorporated | $316M | $21.88 | — | — | Hold | 30.0x | 4 |
CMICummins Inc. | $91.2B | $660.14 | $757.91 | +14.8% | Buy | 22.7x | 51 |
HUBBHubbell Incorporated | $25.5B | $478.89 | $551.33 | +15.1% | Hold | 24.2x | 17 |
ASTEAstec Industries, Inc. | $1.3B | $56.00 | $36.00 | -35.7% | Buy | 15.6x | 12 |
REVGREV Group, Inc. | $3.1B | $63.90 | $33.75 | -47.2% | Hold | 17.2x | 12 |
WNCWabash National Corporation | $500M | $12.29 | $20.00 | +62.7% | Hold | — | 18 |
Quick answers to the most common questions about buying PSIX stock.
The consensus Wall Street price target for PSIX is $107, representing 208.1% upside from the current price of $34.73. With 6 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
PSIX has a consensus rating of "Hold" based on 6 Wall Street analysts. The rating breakdown is mixed, with 4 Hold ratings making up the largest segment. The consensus 12-month price target of $107 implies 208.1% upside from current levels.
With a forward P/E of 14.5924x, PSIX trades at a relatively low valuation. The consensus target of $107 implies 208.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $107 for PSIX, while the most conservative target is $107. The consensus of $107 represents the median expectation. Our quantitative valuation model projects a bull case target of $35 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
PSIX is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PSIX stock forecast based on 6 Wall Street analysts shows a consensus price target of $107, with estimates ranging from $107 (bear case) to $107 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $27, with bear/bull scenarios of $17/$35.
Our quantitative valuation model calculates PSIX's fair value at $27 (base case), with a bear case of $17 and bull case of $35. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
PSIX trades at a forward P/E ratio of 14.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 7.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on PSIX, with a "Hold" consensus rating and $107 price target (208.1% upside). 2 of 6 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PSIX analyst price targets range from $107 to $107, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $107 consensus represents the middle ground. Our model's $17-$35 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.